Robert Smilanich, MD
Vascular Surgery · Provo, UTNPI 1730187600
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,863 of the $5,736 with a category attached, or 67.3%. 8 manufacturers reported payments, led by Medtronic at 32.9% of the total.
Across 45 payments — averaging $127.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- W. L. Gore & Associates, Inc.$1K
- Silk Road Medical, Inc.$1K
- Penumbra, Inc.$1K
- Abbott$87
- Cook Medical LLC$30
- plus $44 from 2 others
What the payments were for
- Travel & lodging$3,86367%
- Food & beverage$1,87333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 22 | $1,886 |
| W. L. Gore & Associates, Inc. | 8 | $1,472 |
| Silk Road Medical, Inc. | 8 | $1,202 |
| Penumbra, Inc. | 2 | $1,015 |
| Abbott | 1 | $87 |
| Cook Medical LLC | 2 | $30 |
| Johnson & Johnson | 1 | $26 |
| Boston Scientific | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$1,247
- Indigo System$1,015
- TurboHawk$911
- ENHANCE Transcarotid Peripheral Access Kit$855
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$797
- ENROUTE Transcarotid Stent System$700
- ENROUTE 0.014 Guidewire$700
- ENROUTE Transcarotid Stent$419
- HawkOne$398
- GORE EXCLUDER Iliac Branch Endoprosthesis$287
- ENROUTE .014 Guidewire$154
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$127
How this compares
$5,736 in reported general payments places this provider in the 75th percentile of 31 vascular surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 21 | $245 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $61 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Provo
- Bradley PansingProvo$3K
- James RiellyProvo$189
- Evan BrownieMurray$206K
- Harrison LazarusWest Jordan$100K
- Brian AdamsOgden$14K
- Craig SelzmanSalt Lake City$11K
- April NedeauOgden$9K
- Douglas WirthlinMurray$9K
- Thomas SerenaSalt Lake City$8K
- Holly RyanSalt Lake City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.